Catalent
CTLT
#1765
Rank
S$14.82 B
Marketcap
S$81.70
Share price
0.00%
Change (1 day)
8.05%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): S-$8.53

According to Catalent's latest financial reports the company's current EPS (TTM) is S-$8.15. In 2023 the company made an earnings per share (EPS) of S-$8.75 a decrease over its 2022 EPS that were of S$2.92.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$8.53-2.55%
2023S-$8.75-399.56%
2022S$2.92-30.58%
2021S$4.2179.67%
2020S$2.34114.12%
2019S$1.09-15%
2018S$1.2975.44%
2017S$0.73-22.97%
2016S$0.95-59.56%
2015S$2.36282.05%
2014S$0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
S-$0.42-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.97-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
S-$7.67-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
S-$1.90-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA